Mycobacterium Tuberculosis Market Report 2026

Mycobacterium Tuberculosis Market Overview

• Mycobacterium Tuberculosis market size has reached to $3.73 billion in 2025 • Expected to grow to $4.75 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Rise In Research And Development Fueling The Growth Of The Market Due To Increasing Demand For Innovative Treatment Solutions • Market Trend: Advancements In Automated Tuberculosis Testing For Faster More Accurate Diagnoses • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Mycobacterium Tuberculosis Market?

Mycobacterium tuberculosis is a slow-growing, rod-shaped bacterium that primarily affects the lungs but can also infect other parts of the body. It is the causative agent of tuberculosis (TB), a contagious disease that spreads through airborne droplets when an infected person coughs, sneezes, or speaks. This bacterium has a unique, waxy cell wall composed of mycolic acid, which makes it resistant to desiccation and contributes to its persistence in the environment. The main product types of mycobacterium tuberculosis include instruments, reagents and consumables, and software solutions. Instruments refer to the medical devices and equipment used in TB diagnosis and research. It can be diagnosed using various methods, such as culture-based methods, molecular diagnosis, and immunological tests, and routes of administration include oral and injectable. It is used by several end users, including hospitals, diagnostic laboratories, and research institutions.

What Is The Mycobacterium Tuberculosis Market Growth Forecast?

The mycobacterium tuberculosis market size is expected to see steady growth in the next few years. It will grow to $4.75 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to growth in molecular diagnostics usage, expansion of telemedicine-based tb screening, rising demand for rapid detection kits, increasing government funding for tb elimination, advancement in automated detection systems. Major trends in the forecast period include growing adoption of molecular tb diagnostic technologies, increasing use of rapid antigen and antibody test kits, expansion of culture-based testing in high-burden regions, rising demand for tb screening in research and public health programs, higher utilization of reagents and consumables for routine tb testing.

Global Mycobacterium Tuberculosis Market Segmentation

1) By Product Type: Instruments, Reagents And Consumables, Software Solutions 2) By Diagnostic Method: Culture-Based Methods, Molecular Diagnosis, Immunological Tests 3) By Route Of Administration: Oral, Injectable 4) By End User: Hospitals, Diagnostic Laboratories, Research Institutions Subsegments: 1) By Instruments: Diagnostic Instruments, Detection Instruments, Molecular Diagnostic Instruments, Tuberculosis Culture Systems 2) By Reagents And Consumables: Polymerase Chain Reaction Reagents, Tuberculosis Culture Media, Antigen Kits, Test Strips, Tuberculosis Diagnostic Kits 3) By Software Solutions: Laboratory Information Management Systems (LIMS), Diagnostic Software, Data Management Software, Telemedicine Solutions For TB Diagnosis

What Is The Driver Of The Mycobacterium Tuberculosis Market?

The rise in investments for research and development is anticipated to propel the growth of the mycobacterium tuberculosis market going forward. Research and development is the process of creating new knowledge or improving existing products, services, or technologies through systematic investigation and experimentation. Research and development is rising due to rapid technological advancement, which drives the need for continuous innovation to stay competitive in evolving global markets. Research and development support mycobacterium tuberculosis treatment by enabling the discovery of novel drug candidates that can overcome resistance to existing therapies, thereby improving treatment effectiveness and patient outcomes. For instance, in March 2024, according to a report published by the Foreign, Commonwealth, and Development Office, a UK-based government department, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program to support innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries. With this support, 500,000 people will receive health care, 37,000 people will have their TB detected, and possibly more than 15,000 lives will be saved. Therefore, the rise in investments for research and development will drive the growth of the mycobacterium tuberculosis industry.

Key Players In The Global Mycobacterium Tuberculosis Market

Major companies operating in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, Akonni Biosystems Inc.

Global Mycobacterium Tuberculosis Market Trends and Insights

Major companies operating in the mycobacterium tuberculosis market are focusing on developing advanced solutions, such as automated tuberculosis tests, to offer faster and more accurate results. Automated tuberculosis tests are diagnostic tools that use automated systems and advanced technology to rapidly and accurately detect Mycobacterium tuberculosis and drug resistance with minimal human intervention. For instance, in April 2025, Revvity Inc., a US-based biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval for the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The Auto-Pure 2400 platform's integration with the T-SPOT.TB test improves automated tuberculosis testing by enabling higher volume processing without compromising accuracy. It combines liquid handling and magnetic cell isolation technology, testing up to 24 samples per run and completing Day 1 of testing in under 3.5 hours with minimal user intervention. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, reduced need for repeat testing, and reliable performance in immunocompromised patients.

What Are Latest Mergers And Acquisitions In The Mycobacterium Tuberculosis Market?

In November 2023, Becton Dickinson and Company (BD), a US-based provider of tuberculosis diagnosis, collaborated with Bio Farma to aid Indonesia in eliminating the spread of tuberculosis. The collaboration between BD and Bio Farma aims to improve access to BD's innovative TB diagnostics portfolio and enhance the supply chain for TB solutions in Indonesia. This partnership also provides Bio Farma with an opportunity to deepen its expertise in the development of diagnostic kits. Bio Farma is an Indonesia-based tuberculosis vaccine manufacturer.

Regional Outlook

North America was the largest region in the mycobacterium tuberculosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mycobacterium Tuberculosis Market?

The mycobacterium tuberculosis market consists of revenues earned by entities by providing services such as tuberculosis strain typing and genotyping services, contract research services, biorepository services, and genomic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mycobacterium tuberculosis market also includes sales of diagnostic kits, antibodies, antigens, recombinant proteins, nucleic acid extraction kits, and biosafety equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mycobacterium Tuberculosis Market Report 2026?

The mycobacterium tuberculosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mycobacterium tuberculosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.